Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliott Richelson

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
The International Journal of Neuropsychopharmacology|February 1, 2013
Multi-modality: a new approach for the treatment of major depressive disorderElliott Richelson
The Journal of Clinical Psychiatry|October 14, 2003
Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevanceElliott Richelson
Psychopharmacology Bulletin|July 15, 2003
The clinical relevance of antidepressant interaction with neurotransmitter transporters and receptorsElliott Richelson
The Journal of Clinical Psychiatry|October 7, 2010
New antipsychotic drugs: how do their receptor-binding profiles compare?Elliott Richelson
Mayo Clinic Proceedings|August 26, 2003
Advances in medical management of overactive bladderElliott Richelson, Daniel S Elliott
Life Sciences|June 13, 2003
Neurotensin agonists: possible drugs for treatment of psychostimulant abuseElliott Richelson, Mona Boules, Paul Fredrickson
Neuroscience Letters|October 27, 2010
NT69L blocks ethanol-induced increase of dopamine and glutamate levels in striatum of mouseZhimin Li, Mona Boules, Elliott Richelson
Life Sciences|September 27, 2003
Current topics: brain penetrating neurotensin analogMona Boules, Paul Fredrickson, Elliott Richelson
Expert Opinion on Investigational Drugs|May 11, 2005
Neurotensin agonists as an alternative to antipsychoticsMona Boules, Paul Fredrickson, Elliott Richelson
Peptides|August 3, 2006
Bioactive analogs of neurotensin: focus on CNS effectsMona Boules, Paul Fredrickson, Elliott Richelson
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
The International Journal of Neuropsychopharmacology|February 1, 2013
Multi-modality: a new approach for the treatment of major depressive disorderElliott Richelson
The Journal of Clinical Psychiatry|October 14, 2003
Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevanceElliott Richelson
Psychopharmacology Bulletin|July 15, 2003
The clinical relevance of antidepressant interaction with neurotransmitter transporters and receptorsElliott Richelson
The Journal of Clinical Psychiatry|October 7, 2010
New antipsychotic drugs: how do their receptor-binding profiles compare?Elliott Richelson
Mayo Clinic Proceedings|August 26, 2003
Advances in medical management of overactive bladderElliott Richelson, Daniel S Elliott
Life Sciences|June 13, 2003
Neurotensin agonists: possible drugs for treatment of psychostimulant abuseElliott Richelson, Mona Boules, Paul Fredrickson
Neuroscience Letters|October 27, 2010
NT69L blocks ethanol-induced increase of dopamine and glutamate levels in striatum of mouseZhimin Li, Mona Boules, Elliott Richelson
Life Sciences|September 27, 2003
Current topics: brain penetrating neurotensin analogMona Boules, Paul Fredrickson, Elliott Richelson
Expert Opinion on Investigational Drugs|May 11, 2005
Neurotensin agonists as an alternative to antipsychoticsMona Boules, Paul Fredrickson, Elliott Richelson
Peptides|August 3, 2006
Bioactive analogs of neurotensin: focus on CNS effectsMona Boules, Paul Fredrickson, Elliott Richelson
Pageof 7